Your browser doesn't support javascript.
loading
Autoimmune Neuroinflammatory Diseases: Role of Interleukins.
Khan, Abdul Waheed; Farooq, Mariya; Hwang, Moon-Jung; Haseeb, Muhammad; Choi, Sangdun.
Afiliação
  • Khan AW; Department of Molecular Science and Technology, Ajou University, Suwon 16499, Republic of Korea.
  • Farooq M; Department of Molecular Science and Technology, Ajou University, Suwon 16499, Republic of Korea.
  • Hwang MJ; S&K Therapeutics, Ajou University Campus Plaza 418, 199 Worldcup-ro, Yeongtong-gu, Suwon 16502, Republic of Korea.
  • Haseeb M; Department of Molecular Science and Technology, Ajou University, Suwon 16499, Republic of Korea.
  • Choi S; S&K Therapeutics, Ajou University Campus Plaza 418, 199 Worldcup-ro, Yeongtong-gu, Suwon 16502, Republic of Korea.
Int J Mol Sci ; 24(9)2023 Apr 27.
Article em En | MEDLINE | ID: mdl-37175665
Autoimmune neuroinflammatory diseases are a group of disorders resulting from abnormal immune responses in the nervous system, causing inflammation and tissue damage. The interleukin (IL) family of cytokines, especially IL-1, IL-6, and IL-17, plays a critical role in the pathogenesis of these diseases. IL-1 is involved in the activation of immune cells, production of pro-inflammatory cytokines, and promotion of blood-brain barrier breakdown. IL-6 is essential for the differentiation of T cells into Th17 cells and has been implicated in the initiation and progression of neuroinflammation. IL-17 is a potent pro-inflammatory cytokine produced by Th17 cells that plays a crucial role in recruiting immune cells to sites of inflammation. This review summarizes the current understanding of the roles of different interleukins in autoimmune neuroinflammatory diseases, including multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer's disease, neuromyelitis optica, and autoimmune encephalitis, and discusses the potential of targeting ILs as a therapeutic strategy against these diseases. We also highlight the need for further research to better understand the roles of ILs in autoimmune neuroinflammatory diseases and to identify new targets for treating these debilitating diseases.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Doenças Neuroinflamatórias Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Doenças Neuroinflamatórias Idioma: En Ano de publicação: 2023 Tipo de documento: Article